Related Experiment Video
Updated: Jul 14, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
The changing epidemiology of fungal infections
Cornelia Lass-Flörl1, Stephan Steixner1
1Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, A-6020, Innsbruck, Austria.
Abstract:
Invasive fungal diseases are common complications in critically ill patients and in those with significant underlying imbalanced immune systems. Fungal co-, and/or super-infections are emerging and have become a rising concern within the last few years. In Europe, cases of candidiasis and aspergillosis dominate, followed by mucormycosis in India. Epidemiological studies show an increasing trend in the incidence of all three entities. Parallel to this, a shift within the underlying fungal pathogens is observed. More non-albicans Candida infections and aspergillosis with cryptic species are on the rise; cryptic species may cover intrinsic resistance to azoles and other antifungal drugs. The recent COVID-19 pandemic led to a significantly increasing incidence of invasive fungal diseases among hospitalized patients.
Insights
Invasive fungal diseases, including candidiasis and aspergillosis, are increasing in critically ill patients. Emerging fungal pathogens show resistance to antifungal drugs, a trend exacerbated by the COVID-19 pandemic.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Background:
- Invasive fungal diseases (IFDs) are significant complications in immunocompromised and critically ill patients.
- Fungal co-infections and super-infections are a growing concern, particularly candidiasis, aspergillosis, and mucormycosis.
- Epidemiological trends indicate a rising incidence of these IFDs globally.
Purpose of the Study:
- To highlight the increasing prevalence of IFDs in vulnerable patient populations.
- To identify emerging trends in fungal pathogens, including non-albicans Candida and cryptic Aspergillus species.
- To underscore the impact of the COVID-19 pandemic on IFD incidence.
Main Methods:
- Review of epidemiological data on IFDs in Europe and India.
- Analysis of trends in causative fungal species, including shifts in Candida and Aspergillus populations.
- Assessment of the influence of the COVID-19 pandemic on IFD occurrences.
Main Results:
- Candidiasis and aspergillosis are dominant IFDs in Europe, while mucormycosis is prevalent in India.
- A notable increase in the incidence of these fungal infections has been observed.
- Emergence of non-albicans Candida and cryptic Aspergillus species, potentially exhibiting antifungal resistance, is on the rise.
- The COVID-19 pandemic has significantly increased the incidence of IFDs in hospitalized patients.
Conclusions:
- IFDs represent a growing threat, particularly in immunocompromised individuals and those critically ill.
- The changing landscape of fungal pathogens necessitates vigilance regarding antifungal resistance.
- The COVID-19 pandemic has amplified the burden of IFDs, demanding urgent clinical and research attention.
More Related Videos
Related Concept Videos
Fungal Phylum Microsporidia
Overview of Fungi
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Group Zygomycota
Fungal Phylum Ascomycota

